March 5, 2026 · Form 4 insider transaction
Pegels Kevin Carl bought 7,369 shares of Illumina, Inc. at $128.24 per share, a transaction worth $945.0K. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 4 days after the transaction.
Each performance stock unit represents a contingent right to receive one share of common stock based on the Company's three-year average consolidated non-GAAP earnings per share growth for fiscal years 2026-2028 with vesting on December 31, 2028. The number of shares issued will range from 0% to 250% of the amount specified above, based on the Company's actual three-year average consolidated non-GAAP earnings per share growth for fiscal years 2026-2028, relative to pre-defined objectives, subject to awardee's continuing to be a service provider on such dates.